Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 176

1.

Protein kinase D3 (PKD3) contributes to prostate cancer cell growth and survival through a PKCepsilon/PKD3 pathway downstream of Akt and ERK 1/2.

Chen J, Deng F, Singh SV, Wang QJ.

Cancer Res. 2008 May 15;68(10):3844-53. doi: 10.1158/0008-5472.CAN-07-5156.

2.

A protein kinase C/protein kinase D pathway protects LNCaP prostate cancer cells from phorbol ester-induced apoptosis by promoting ERK1/2 and NF-{kappa}B activities.

Chen J, Giridhar KV, Zhang L, Xu S, Wang QJ.

Carcinogenesis. 2011 Aug;32(8):1198-206. doi: 10.1093/carcin/bgr113. Epub 2011 Jun 10.

3.

Protein kinase C promotes apoptosis in LNCaP prostate cancer cells through activation of p38 MAPK and inhibition of the Akt survival pathway.

Tanaka Y, Gavrielides MV, Mitsuuchi Y, Fujii T, Kazanietz MG.

J Biol Chem. 2003 Sep 5;278(36):33753-62. Epub 2003 Jun 24.

4.

Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.

Weiss-Messer E, Merom O, Adi A, Karry R, Bidosee M, Ber R, Kaploun A, Stein A, Barkey RJ.

Mol Cell Endocrinol. 2004 May 31;220(1-2):109-23.

PMID:
15196705
5.

Effect of zinc on regulation of insulin-like growth factor signaling in human androgen-independent prostate cancer cells.

Banudevi S, Senthilkumar K, Sharmila G, Arunkumar R, Vijayababu MR, Arunakaran J.

Clin Chim Acta. 2010 Feb;411(3-4):172-8. doi: 10.1016/j.cca.2009.10.023. Epub 2009 Nov 11.

PMID:
19913001
6.

Focal adhesion kinase controls aggressive phenotype of androgen-independent prostate cancer.

Johnson TR, Khandrika L, Kumar B, Venezia S, Koul S, Chandhoke R, Maroni P, Donohue R, Meacham RB, Koul HK.

Mol Cancer Res. 2008 Oct;6(10):1639-48. doi: 10.1158/1541-7786.MCR-08-0052.

7.
8.

Radiation-stimulated ERK1/2 and JNK1/2 signaling can promote cell cycle progression in human colon cancer cells.

Carón RW, Yacoub A, Mitchell C, Zhu X, Hong Y, Sasazuki T, Shirasawa S, Hagan MP, Grant S, Dent P.

Cell Cycle. 2005 Mar;4(3):456-64. Epub 2005 Mar 28.

PMID:
15655348
11.

Serotonin activates MAP kinase and PI3K/Akt signaling pathways in prostate cancer cell lines.

Dizeyi N, Hedlund P, Bjartell A, Tinzl M, Austild-Taskén K, Abrahamsson PA.

Urol Oncol. 2011 Jul-Aug;29(4):436-45. doi: 10.1016/j.urolonc.2009.09.013. Epub 2009 Nov 19.

PMID:
19926313
12.

hPEBP4 resists TRAIL-induced apoptosis of human prostate cancer cells by activating Akt and deactivating ERK1/2 pathways.

Li H, Wang X, Li N, Qiu J, Zhang Y, Cao X.

J Biol Chem. 2007 Feb 16;282(7):4943-50. Epub 2006 Dec 18.

13.

Increased AKT activity contributes to prostate cancer progression by dramatically accelerating prostate tumor growth and diminishing p27Kip1 expression.

Graff JR, Konicek BW, McNulty AM, Wang Z, Houck K, Allen S, Paul JD, Hbaiu A, Goode RG, Sandusky GE, Vessella RL, Neubauer BL.

J Biol Chem. 2000 Aug 11;275(32):24500-5.

14.

Regulation of prostate cancer cell survival by protein kinase Cepsilon involves bad phosphorylation and modulation of the TNFalpha/JNK pathway.

Meshki J, Caino MC, von Burstin VA, Griner E, Kazanietz MG.

J Biol Chem. 2010 Aug 20;285(34):26033-40. doi: 10.1074/jbc.M110.128371. Epub 2010 Jun 21.

15.

Akt down-regulates ERK1/2 nuclear localization and angiotensin II-induced cell proliferation through PEA-15.

Gervais M, Dugourd C, Muller L, Ardidie C, Canton B, Loviconi L, Corvol P, Chneiweiss H, Monnot C.

Mol Biol Cell. 2006 Sep;17(9):3940-51. Epub 2006 Jul 5.

16.

Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.

Unni E, Sun S, Nan B, McPhaul MJ, Cheskis B, Mancini MA, Marcelli M.

Cancer Res. 2004 Oct 1;64(19):7156-68.

17.

Sinodielide A exerts thermosensitizing effects and induces apoptosis and G2/M cell cycle arrest in DU145 human prostate cancer cells via the Ras/Raf/MAPK and PI3K/Akt signaling pathways.

Hatashita M, Taniguchi M, Baba K, Koshiba K, Sato T, Jujo Y, Suzuki R, Hayashi S.

Int J Mol Med. 2014 Feb;33(2):406-14. doi: 10.3892/ijmm.2013.1568. Epub 2013 Nov 27.

PMID:
24285252
18.

Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells.

Gan Y, Shi C, Inge L, Hibner M, Balducci J, Huang Y.

Oncogene. 2010 Sep 2;29(35):4947-58. doi: 10.1038/onc.2010.240. Epub 2010 Jun 21.

PMID:
20562913
19.

[PKD3 contributes to up-regulation of prostate-specific antigen in prostate cancer cells].

Deng F, Wang CX, Xu WF, Feng L, Ke ZY, Wang QJ, Zou ZP.

Nan Fang Yi Ke Da Xue Xue Bao. 2010 Aug;30(8):1779-82. Chinese.

20.

STAMP1 is both a proliferative and an antiapoptotic factor in prostate cancer.

Wang L, Jin Y, Arnoldussen YJ, Jonson I, Qu S, Maelandsmo GM, Kristian A, Risberg B, Waehre H, Danielsen HE, Saatcioglu F.

Cancer Res. 2010 Jul 15;70(14):5818-28. doi: 10.1158/0008-5472.CAN-09-4697. Epub 2010 Jun 29.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk